Nanologica AB (publ)

kr 0.17As of Sun 8 Nov 2026, 12:00 UTC
STO:NICAHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (37.31%)
Div yield —
ROE 18.07%
Biotechnology
Beta (5Y) 0.02
PE TTM 1.763
TSR TTM (86.39%)
Mkt cap kr 55.89M
ROIC 6.38%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.186
9.38%
(66.81%)
Buy 10|4|9|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
—
—
—
—
9.76%
7.10%
1.04%
8.27%
Revenuekr M
2.560
2.567
2.542
2.476
0.76%
0.76%
(2.94%)
(5.47%)
Peers (US$5.651M)
Cap (US$)
PE
6.612M
—
5.675M
18.97x
Capital
TTM
5Y
10Y
Leveragex
0.903
0.090
0.067
EBIT/Intx
0.831
0.199
0.198
Own earn%
(101.21)
(25.75)
(5.76)
Sh yield%
25.62
42.50
36.61
Owners
Insiders/Inst%
6.05
76.47
Short interest%
4.47
SBC / revenue%
2.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
15–20
$1 testx
0.8
Incr. ROIC%
3